跳至主要内容
临床试验/NL-OMON55155
NL-OMON55155已完成不适用

Integration of medical, psychiatric and behavioural care for the substantiated and appropriate use of psychotropic drugs in individuals with an intellectual disability and challenging behaviour. - CHALIDIT-CRT

GGZ Drenthe (Assen)0 个研究点目标入组 106 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
106

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12 至 99(—)

入选标准

  • - Person with a moderate to profound intellectual disability (level of
  • cognitive development < 6 years)
  • - Age > 12 years
  • - Off-label psychotropic drug use for more than one year
  • - Informed consent (IC) signed by participant and/or participant representative
  • (depending on the competence of the participant)

排除标准

  • A diagnosis of, classified according to DSM-5 criteria:
  • - Dementia
  • - Chronic psychotic disorder
  • - Schizoaffective disorder
  • - Bipolar disorder type I
  • - Significant life event in the past six months

研究者

发起方
GGZ Drenthe (Assen)

相似试验